In the US, psychopharmacology has been in existence for approximately 70 years since the FDA approval of Thorazine (1952). Much of the research focus has been on group differences associated with age and gender. Surprisingly, little research has focused on different ethnoracial groups. This presentation will look at differences in how medications are absorbed, distributed and metabolized (known as pharmacokinetics) across groups. In addition, there are differences in how ethnoracial groups view the value of psychotropic medication including medication adherence, another area to be discussed within this workshop.